Neutrolis Inc.
Biotechnology company · Cambridge, Massachusetts, United States
Neutrolis Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2017. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $461,244 in total, most recently in 2020. It has reported private securities offerings to the US SEC, most recently $3.5 million sold in a notice filed in 2025.
Neutrolis at a glance
What does Neutrolis do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $461,244 in total (2020). NIH funding came from the National Heart, Lung, and Blood Institute, National Institute of Allergy and Infectious Diseases.
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $3.5 million sold (2025).
Frequently asked questions about Neutrolis
Where is Neutrolis headquartered?
Neutrolis Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Neutrolis do?
Neutrolis Inc. is a biotechnology company.
When was Neutrolis founded?
The earliest incorporation on record for Neutrolis Inc. is in 2017, according to public company registers.
Similar companies
- Editas Medicine, Inc.Cambridge, Massachusetts, United States
- Moderna, Inc.Cambridge, Massachusetts, United States
- Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
- Beam Therapeutics Inc.Cambridge, Massachusetts, United States
- Epicore Biosystems, Inc.Cambridge, Massachusetts, United States
- Genzyme CorpCambridge, Massachusetts, United States
- Biogen Inc.Cambridge, Massachusetts, United States
- Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.